Université Grenoble Alpes, IAB, Team of Environmental Epidemiology Applied to Reproduction and Respiratory Health, Grenoble, France; Inserm, IAB, Team of Environmental Epidemiology Applied to Reproduction and Respiratory Health, Grenoble, France; CHU de Grenoble, IAB, Team of Environmental Epidemiology applied to Reproduction and Respiratory Health, Grenoble, France.
Université Grenoble Alpes, IAB, Team of Environmental Epidemiology Applied to Reproduction and Respiratory Health, Grenoble, France; Inserm, IAB, Team of Environmental Epidemiology Applied to Reproduction and Respiratory Health, Grenoble, France; CHU de Grenoble, IAB, Team of Environmental Epidemiology applied to Reproduction and Respiratory Health, Grenoble, France.
J Allergy Clin Immunol. 2016 Jun;137(6):1709-1716.e6. doi: 10.1016/j.jaci.2015.10.029. Epub 2015 Dec 11.
Whether small-airway obstruction contributes to the long-term evolution of asthma remains unknown.
Our aim was to assess whether the level of forced midexpiratory flow between 25% and 75% of forced vital capacity (FEF25-75) was associated with the persistence of current asthma over 20 years and the subsequent risk for uncontrolled asthma independently of FEV1.
We studied 337 participants (142 children and 225 adults) with current asthma (asthma attacks or treatment in the past 12 months) recruited to the Epidemiological Study on the Genetics and Environment of Asthma (EGEA1) and followed up at the 12- and 20-year surveys. Persistent current asthma was defined by current asthma reported at each survey. A lung function test and a methacholine challenge test were performed at EGEA1 and EGEA2. Adjusted odds ratios (ORs) were estimated for FEF25-75 decreased by 10% of predicted value.
A reduced level of FEF25-75 at EGEA1 increased the risk of long-term asthma persistence (adjusted OR, 1.14; 95% CI, 1.00-1.29). In children the association remained significant after further adjustment for FEV1 and in participants with FEV1 of greater than 80% of predicted value. A reduced FEF25-75 level at EGEA1 was significantly associated with more severe bronchial hyperresponsiveness (P < .0001) and with current asthma a decade later, with an association that tended to be stronger in those with (adjusted OR, 1.44; 95% CI, 1.14-1.81) compared with those without (adjusted OR, 1.21; 95% CI, 1.05-1.41) asthma exacerbation.
Our analysis is the first to suggest that small-airway obstruction, as assessed based on FEF25-75, might contribute to the long-term persistence of asthma and the subsequent risk for poor asthma outcomes independently from effects of the large airways.
小气道阻塞是否会导致哮喘的长期进展尚不清楚。
我们旨在评估用力呼出 25%至 75%肺活量时的中间流量(FEF25-75)水平是否与 20 年期间当前哮喘的持续存在以及随后发生不受控制的哮喘的风险相关,而不受 FEV1 的影响。
我们研究了 337 名参与者(142 名儿童和 225 名成人),他们患有当前的哮喘(过去 12 个月内有哮喘发作或治疗),被招募到遗传与环境对哮喘的流行病学研究(EGEA1)中,并在 12 年和 20 年的调查中进行了随访。通过在每次调查中报告当前哮喘来定义持续的当前哮喘。在 EGEA1 和 EGEA2 进行了肺功能测试和乙酰甲胆碱激发试验。估计了 FEF25-75 降低 10%预测值的调整比值比(OR)。
EGEA1 时 FEF25-75 水平降低增加了长期哮喘持续存在的风险(调整 OR,1.14;95%CI,1.00-1.29)。在儿童中,在进一步调整 FEV1 后,这种关联仍然显著,并且在 FEV1 大于预测值 80%的参与者中也是如此。EGEA1 时 FEF25-75 水平降低与更严重的支气管高反应性显著相关(P<.0001),并且与 10 年后的当前哮喘相关,这种关联在那些没有(调整 OR,1.21;95%CI,1.05-1.41)或有(调整 OR,1.44;95%CI,1.14-1.81)哮喘加重的参与者中似乎更强。
我们的分析首次表明,小气道阻塞,如基于 FEF25-75 的评估,可能导致哮喘的长期持续存在以及随后发生不良哮喘结局的风险,而不受大气道的影响。